Overview
Medical Inventi is a company that develops and commercializes innovative medical products, focusing on improving patient quality of life. It specializes in FlexiOss®, the world's first flexible bone substitute biomaterial, which integrates naturally with patient bone and is used in orthopedics, dentistry, and veterinary medicine to fill bone defects. The company holds exclusive know-how, technologies, and patents related to FlexiOss®.
Financials
The financial statement for 2025 has not yet been filed with the Financial Document Repository (past deadline).
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2024.
Results vs industry
News
FlexiOss® presented in Cebu, Philippines
FlexiOss® presented at Baguio General Hospital and Medical Center
FlexiOss®Vet at the EVDF Congress in Porto
Medical Inventi participates in WHX Dubai (February 9–12)
Medical Inventi S.A. at WHX Dubai 2026 trade fair
FlexiOss®Vet strengthens its position in European markets
Industry
Bank accounts
Registered as a VAT taxpayer on 2011-06-28. Active
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
MSiG notices
8 notices recorded in the Court and Commercial Gazette (MSiG).
| Publication date | Event | |
|---|---|---|
| May 19, 2026 | Commercial Companies Code notice | |
| Aug 21, 2020 | Commercial Companies Code notice | |
| Nov 6, 2018 | Commercial Companies Code notice | |
| Jan 5, 2016 | Call to creditors | |
| Nov 12, 2015 | Call to creditors |
Public aid
57 public aid cases recorded, with a total value of $2,303,342.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 25, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $1,960 | Marszałek Województwa Lubelskiego | |
| Mar 4, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $25,613 | Marszałek Województwa Lubelskiego | |
| Jan 28, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $32,415 | Marszałek Województwa Lubelskiego |
European Funds
8 projects co-financed from European Funds recorded, with total EU co-financing of $897,499.
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2025-03-17 | Opracowanie technologii dostarczania leków do organizmu, wraz z aplikacją produktów kościozastępczych serii FlexiOss Vet | $58,702 | Fundusze Europejskie dla Lubelskiego 2021-2027 | |
| 2023-11-02 | FlexiOss dla weterynarii - ekspansja na rynki zagraniczne | $39,861 | Fundusze Europejskie dla Lubelskiego 2021-2027 | |
| 2023-07-01 | Zwiększenie konkurencyjności Medical Inventi poprzez badania i wdrożenie dwufazowego biomateriału do regeneracji ubytków chrzęstno - kostnych. | $219,344 | Fundusze Europejskie dla Lubelskiego 2021-2027 |
Tenders
1 tender recorded as contractor, with a total value of $437,251.
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Jun 5, 2025 | Dostawy opatrunków, obłożeń i innego sprzętu z podziałem na części | $437,251 | Wojewódzki Szpital Dziecięcy Im. J. Brudzińskiego w Bydgoszczy |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
In the case of a one-person management board or a two-person management board, each member of the management board is authorised to submit declarations of will on behalf of the company independently. If the management board consists of at least three members, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to submit declarations of will on behalf of the company.
Supervisory board
Beneficial owners
| Person | Rights |
|---|---|
Anna Barbara Kasprzak-Czelej (47)  | Osoba fizyczna zajmująca wyższe stanowisko kierownicze, wiceprezes zarządu |
Maciej Jacek Maniecki (64) | Osoba fizyczna zajmująca wyższe stanowisko kierownicze, prezes zarządu |
Competitors
| Name | Revenue | Website | |
|---|---|---|---|
| AmbioP.S.A. | $1,357,457.41 | ambio.com.pl | |
| Endotradesp. z o.o. | $912,862.33 | endotrade.pl | |
| Implaisp. z o.o. | $661,746.96 | implai.com | |
| Salon Ortopedyczny Or-Techsp. z o.o. | $453,978.03 | or-tech.pl | |
| EndolinkS.A. | $378,334.26 | endolink.pl | |
| ChitomedP.S.A. | $206,587.41 | chitomed.com | |
| Orto Novasp. z o.o. | $158,631.83 | zarychta.com.pl | |
| Astendsp. z o.o. | $105,928.35 | astend.pl | |
| Medo Techsp. z o.o. | $60,201.80 | medotech.pl | |
| Smart Labssp. z o.o. | $32,047.41 | smart-labs.pl |
Change history
| Date | Event |
|---|---|
| 2026-06-10 | Share capital change (344,094.70 PLN → 460,407.30 PLN) |
| 2025-02-24 | Share capital change (340,382.20 PLN → 344,094.70 PLN) |
| 2024-06-28 | Share capital change (320,271.50 PLN → 340,382.20 PLN) |
| 2023-03-22 | Share capital change (305,221.50 PLN → 320,271.50 PLN) |
| 2022-01-13 | Share capital change (267,721.50 PLN → 305,221.50 PLN) |
FAQ
Last updated: 2026-06-12